Continuing a push to bulk up in California as well as in its life sciences practice, Goodwin has added patents and innovations partner Sabrina Poulos to its San Francisco office. Read the feature announcement in The American Lawyer here.
Related Content
- Big Molecule WatchApril 15, 2025
FDA to Phase Out Animal Testing for Monoclonal Antibodies and Other Drugs
- AlertApril 15, 2025
Life Sciences Companies Must Navigate the DOJ Data Rule
- Big Molecule WatchApril 11, 2025
FDA Approves Biocon Biologics’ Bevacizumab Biosimilar
- Big Molecule WatchApril 9, 2025
Teva and Samsung Bioepis Announce U.S. Launch of EPYSQLI® (eculizumab-aagh), a SOLIRIS® Biosimilar
- Big Molecule WatchApril 7, 2025
GSK and Pfizer Stipulate to Dismissal of RSV Vaccines Lawsuit
- Big Molecule WatchApril 7, 2025
EMA Seeks Input on a “Tailored Clinical Approach” in Biosimilar Development
- Big Molecule WatchApril 7, 2025
Accord Receives Positive EMA Opinion for Two Denosumab Biosimilars
- Big Molecule WatchApril 3, 2025
Global Biosimilar Updates – Spring 2025
- In the PressApril 11, 2025
Radiopharmaceuticals M&A to go Nuclear over Production Demand, Novel Drugs (Mergermarket)
- EventsApril 8, 2025
Boston Forum: Merger Control & Competition in Life Sciences
- Awards and RankingsApril 7, 2025
Goodwin Is Top Law Firm for Global M&A for Q1 2025
- EventsMarch 27, 2025
Goodwin’s Annual Healthcare & Life Sciences Summit
- In the PressMarch 27, 2025
AI Valuations ‘Miles Ahead of’ Regular Tech, Says Goodwin Panel; Spring Statement Gives ‘Greater Confidence’ to Defense Investors (PE HUB)
- Awards and RankingsMarch 26, 2025
The Legal 500 EMEA 2025 Recognizes Goodwin for Excellence Across Europe
- Press ReleaseMarch 24, 2025
Goodwin Advised Harbour BioMed in $175 Million Global Strategic Collaboration with AstraZeneca to Discover and Develop Next-Generation Therapeutic Antibodies
- In the PressMarch 21, 2025
Leading the Charge in Life Sciences Litigation, Goodwin is Shortlisted For Three Managing IP Awards